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Abstract
Introduction. The Multilevel EDucational and MOtivational intervention in patients after myocardial infarcTION (MED-
MOTION) project has been designed to test the comprehensive strategy of treatment after acute coronary syndrome. 
The aim of MEDMOTION is to improve the efficacy of secondary prevention, complementing patients’ education with 
motivational interventions.
Material and methods. Individualised motivation and complex health education, started during hospitalisation and 
continued after discharge, explaining the pathophysiology and symptoms of the disease, elucidating goals and potential 
benefits of treatment, and highlighting the risk of premature termination of therapy, with the use of additional methods 
helping patients to remember the treatment schedule, will be applied to enhance adherence to treatment, resulting in 
improved clinical outcomes. Interventions targeting the attitudes and knowledge of nurses and physicians form part of 
the MEDMOTION project, including analysis of the strengths and weaknesses of medical staff in the context of motiva-
tion and therapeutic education, workshops on interpersonal (medical staff and patient) communication, motivational 
and educational strategies.
Conclusion. We believe that motivational actions, complementing educational interventions, are essential for successful 
secondary prevention after ACS.
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Introduction
A widespread belief exists that better education of patients 
might improve clinical outcomes after acute coronary 
syndrome (ACS) due to the impact on cardiovascular risk 
factors (CVRFs) management [1, 2]. Lifestyle modifications 
and adherence to treatment has been shown to be effective 
in CVRFs management and to reduce major cardiovascular 
adverse events (MACE) [3, 4]. On the other hand, many 
patients do not follow medical recommendations [5, 6]. 
Early, in-hospital initiation of a preventive strategy including 
education and motivation might increase the likelihood of 
successful treatment [7, 8].
We have designed Multilevel EDucational and MOtiva-
tional intervention in patients after myocardial infarcTION 
(MEDMOTION) to test the comprehensive strategy of tre-
atment after ACS.
The aim of MEDMOTION is to improve the efficacy of 
secondary prevention, complementing patient education 
with motivational interventions.
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MI promotes partnership-oriented counselling interven-
tions of healthcare staff with the patient. It departs from 
the traditional prescriptive approach that relies on expert- 
-driven persuasion by instead encouraging counselling, ex-
hortation and support leading to patient-driven change ini-
tiation. Conducive to change implementation is the creation 
of a positive atmosphere and a collaborative relationship 
with the patient. Change elicitation results from evoking 
the patient’s intrinsic motivation for behavioural change 
by drawing on personally meaningful goals. The patient’s 
autonomy is fully respected, which entails shifting the de-
cision to implement behavioural changes and the respon-
sibility of change implementation outcomes from medical 
staff to patient.
Thus, change is not imparted but elicited, and, in con-
sequence, is highly effective in sustained self-control in-
stigating lifestyle changes. The four underlying principles 
that guide MI involve expressing empathy by medical staff, 
emphasising discrepancy between the current state and 
the patients’ future well-being, ‘rolling’ with patients’ resis-
tance to change, and bolstering their self-efficacy and self-
regulation [16]. These principles are immersed in a specific 
style of interpersonal communication which boils down to 
the keywords mentioned above, i.e. collaboration, evoca-
tion, and autonomy.
The MI approach to medical recommendations adhe-
rence in both in-hospital and post-discharge ACS patients 
is one of many methods that may boost patients’ intrinsic 
motivation to maintain lifestyle modifications and enhance 
the long-term efficacy of CVRF management measures. Po-
tentially, it may entail interventions resulting in the three 
key areas of post-ACS therapy: dietary changes, physical 
activity, and medication adherence. However, some train-
ing of healthcare staff is needed in education and support 
provision, and in interpersonal communication, as well as in 
patients’ intrinsic motivation evocation and enhancement.
To allow direct efficacy evaluation of educational and 
motivational interventions, a comprehensive post-ACS in-
-hospital patient evaluation regarding readiness for hospi-
tal discharge is planned, as well as a post-discharge as-
sessment of adherence to pharmacological treatment and 
functioning in the follow-up phase, and the use of dedicated 
self-reported questionnaires. It is expected that a compre-
hensive, multi-stage assessment of patients would impro-
ve the quality of medical care by personalising educational 
and therapeutic interventions [24, 25]. The Readiness for 
Hospital Discharge after Myocardial Infarction Scale (RHD-
-MIS) [26] was designed for in-hospital evaluation, while 
the Adherence in Chronic Diseases Scale (ACDS) [27–30] 
and the Functioning in Chronic Illness Scale (FCIS) [31, 32] 
were devised for the examination during follow-up visits.
The RHD-MIS was developed as a tool to improve the 
quality of the discharge process, enabling assessment of 
the patients’ knowledge, expectations and concerns, as 
Material and methods
The MEDMOTION project has been designed as a multicen-
tre study with a two-year follow-up. After the observational 
phase of the study, a randomised, open-label, multicentre 
study phase is planned. The project is currently in the 
initiation phase.
We assumed that individualised, motivation and com-
plex health education started during hospitalisation and 
continued after discharge, explaining the pathophysiology 
and symptoms of the disease, elucidating goals and po-
tential benefits of treatment, and highlighting the risk of 
premature termination of therapy, with the use of additio-
nal methods helping patients to remember the treatment 
schedule, will enhance adherence to treatment and  result 
in improved clinical outcomes [9–11].
Educational and motivational interventions within the 
MEDMOTION project will be applied as standardised proce-
dures according to the previous experience of the Guideli-
nes Applied to Practice (GAP) project [12]. The introduction 
of quality improvement procedures resulted in mortality 
reduction at 12 months. However, comparison of outco-
mes obtained in 11 control ‘wanting to improve’ hospitals 
that were not selected as one of the 10 GAP intervention 
hospitals demonstrated that the control hospitals did not 
achieve the level of change observed in the participating 
hospitals [13].
According to the findings of the meta-analysis by Auer 
et al. [14], interventions may be more effective when they 
target not only the patient but also the providers and the 
healthcare system.
Considering these findings, several interventions tar-
geting the attitudes and knowledge of nurses and physi-
cians are being conducted as a part of the MEDMOTION 
project, including analysis of the strengths and weakness-
es of medical staff in the context of motivation and thera-
peutic education, workshops on interpersonal (medical 
staff and patient) communication, motivational and edu-
cational strategies.
One highly efficient way to achieve motivation for intro-
ducing dietary changes and healthy lifestyle behaviour of 
post-ACS patients is a motivational interview (MI) by medi-
cal and healthcare staff. MI is a widely used, scientifical-
ly-tested and clinically relevant method developed by Mil-
ler and Rollnick [15, 16] of patient counselling in primary 
and secondary care, successfully applied to a number of 
diseases and addictions. Effective application of both in-
-hospital MI interventions on cardiovascular disease risk 
factors as well as of post-discharge behavioural interven-
tions (telephone-based, text messages) have been already 
reported [17–21]. MI has been also successfully used for 
lifestyle problems which are however closely connected with 
ACS interventions, inter alia for weight loss and smoking 
cessation [22], as well as for medication adherence [23].
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well as identifying any field requiring additional interven-
tion in clinical conditions [26]. The questionnaire consists 
of 23 questions: 16 self-reported by patients (a subjecti-
ve assessment of patients’ knowledge — seven items, and 
expectations — nine items) and seven assessed by the me-
dical staff during a consultation with the patient (an objec-
tive assessment of patients’ knowledge). An additional five 
not-scored items reflect the patient’s situation [26, 32].
The ACDS is a reliable tool allowing the identification 
of subjects prone not to follow the prescribed therapy [27]. 
Moreover, it determines the most common non-adherence 
reasons. This simple and easy-to-apply in everyday practi-
ce questionnaire has the potential to improve adherence 
to treatment and clinical outcome. All seven items refer 
to determinants of adherence associated with behaviours 
and factors that can indirectly influence adherence and 
are related to situations and patients’ convictions [27–30].
The FCIS has been designed for comprehensive as-
sessment of the overall functioning of the patient in chro-
nic disease [31]. The impact of the disease essentially co-
vers all areas of human functioning, including the physical, 
emotional and spiritual spheres, as well as functioning in 
society [31, 32]. The questionnaire consists of 24 que-
stions divided into three parts evaluating the impact of 
the disease on the patient (eight items), the patients’ im-
pact on the disease (eight items), and the impact of the 
disease on patients’ attitudes (eight items). The FICS eva-
luates various aspects of how patients function with chro-
nic disease in a quick and simple way, allowing the diag-
nosis of deficit areas in order to implement appropriate 
therapeutic and educational interventions [31]. The appli-
cation of this diagnostic comprehensive strategy based on 
self-reported questionnaires previously tested in patients 
with coronary artery disease after ACS treated with PCI is 
planned to guide additional motivational and educational 
interventions application.
Discussion
Several multiple studies evaluating interventions targeting 
an increase in long-term adherence to treatment by pa-
tients have been previously performed [19, 33–36]. Ockene 
et al. [37] proposed a categorisation of interventions ana-
lysing long-term adherence on the basis of a conceptual 
model that considers the levels of intervention. The first tier, 
patient-level interventions address patients directly through 
counselling, education, or patient-specific order sets [37]. 
The second tier, healthcare provider-level interventions 
concern the attitudes or knowledge of healthcare providers 
(e.g. improving physicians’ skills and effectiveness in coun-
selling through an educational programme or education/ 
/reminders on the benefits of specific therapies) [37, 38]. 
The third tier, system-level interventions investigate global 
change in the organisation of care (e.g. critical pathways 
or facility outcome reporting) [37, 39].
Recognising this categorisation of interventions, Auer 
et al. [14] conducted a systematic review and meta-analy-
sis to determine whether in-hospital secondary prevention 
interventions improve outcomes of patients who have suf-
fered an acute coronary syndrome. The systematic review 
included at least patient-level interventions, with some ope-
rating additionally at the provider and/or system levels in 
16 clinical controlled trials (2,467 patients) and in 10 be-
fore-and-after studies (38,581 patients) [14].
The overall pooled relative risk (RR) for all-cause mor-
tality between the intervention and control groups was 
0.78 [95% confidence interval (CI): 0.71–0.86) using 
a random-effect model. The favourable result was mainly 
driven by results obtained in before-and-after studies that 
examined 3,680 deaths RR = 0.77 (95% CI: 0.66–0.90), 
while no benefit was observed in clinical controlled trials 
RR = 0.96 (95% CI: 0.64–1.44) based on analysis of 
99 deaths. Moreover, if the intervention involved only 
patients through counselling and education, the RR was 
0.93 (95% CI: 0.63–1.36), whereas it was 0.77 (95% CI: 
0.65–0.92) if the intervention also included a provider-
-level or system-level intervention. However, continuation 
of interventions in an outpatient setting was not asso-
ciated with better outcomes compared to in-hospital in-
terventions only (RR = 0.84, 95% CI: 0.58–1.22 vs. RR 
= 0.78, 95% CI: 0.65–0.94 respectively) [14]. The RR 
for reinfarction was 0.59 (95% CI: 0.32–1.07), however 
substantial heterogeneity (p = 0.04) was observed, thus 
the results should be considered with caution. For befo-
re-and-after studies that examined only 41 reinfarctions, 
RR was 0.81 (95% CI: 0.20–3.31), while for clinical trials 
the RR was 0.51 (95% CI: 0.23–1.13) based on analysis 
of 87 reinfarctions [14].
The evidence of the impact of interventions aimed at 
increasing long-term adherence to treatment on mortality 
is promising, but not definitive because it was seen in be-
fore-and-after studies only, not in clinical controlled trials 
[14]. Accordingly, a large scale randomised controlled cli-
ni cal trial comparing prevention interventions with usual 
care is needed.
The MEDMOTION project answers this call. The non- 
-systematic review previously published by Duryee showed 
no benefits from in-hospital education after myocardial in-
farction that considered only isolated patient-level inter-
ventions [1]. Therefore, the MEDMOTION project will ap-
ply multilevel (in-hospital, early post-discharge — up to the 
end of the first year, and late post-discharge — up to the 
end of the second year of follow-up), standardised (stan-
dard MEDMOTION brochures, scenarios and scales), and 
personalised educational and motivational interventions 
(tools selected according to personal needs).
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Conclusion
We believe that motivational actions complementing educa-
tional interventions are essential for successful secondary 
prevention after ACS.
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Streszczenie
Wstęp. Wielopoziomowę interwencję edukacyjną i motywacyjną u pacjentów po zawale serca [Multilevel EDucational 
and MOtivational intervention in patients after myocardial infarcTION (MEDMOTION)] zaprojektowano w celu przetesto-
wania kompleksowej strategii leczenia po ostrym zespole wieńcowym (ACS). Celem projektu MEDMOTION jest poprawa 
skuteczności profilaktyki wtórnej poprzez uzupełnienie edukacji pacjentów interwencjami motywacyjnymi.
Materiał i metody. Zindywidualizowana motywacja i kompleksowa edukacja zdrowotna rozpoczęta podczas hospitalizacji 
i kontynuowana po wypisaniu, wyjaśniając patofizjologię i objawy choroby, ukazując cele i potencjalne korzyści leczenia 
oraz podkreślając ryzyko przedwczesnego zakończenia terapii, z wykorzystaniem dodatkowych metod pomagających 
pacjentom pamiętać harmonogram leczenia, zostaną zastosowane w celu poprawy przestrzegania zaleceń terapeu-
tycznych oraz uzyskania lepszych wyników leczenia. Interwencje ukierunkowane na postawy i wiedzę pielęgniarek oraz 
lekarzy, stanowiące część projektu MEDMOTION, obejmują analizę mocnych i słabych stron personelu medycznego 
w kontekście motywacji i edukacji terapeutycznej, warsztaty na temat komunikacji interpersonalnej (między personelem 
medycznym a pacjentem), stosowania strategii motywacyjnych i edukacyjnych.
Wniosek. Zdaniem autorów działania motywujące uzupełniające interwencje edukacyjne są niezbędne do skutecznej 
prewencji wtórnej po ACS.
Słowa kluczowe: motywacja, edukacja
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